Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.91 by 6.28 percent. This is a 12.15 percent increase over earnings of $1.81 per share from the same period last year. The company reported quarterly sales of $6.960 billion which beat the analyst consensus estimate of $6.913 billion by 0.68 percent. This is a 4.39 percent increase over sales of $6.667 billion the same period last year.